greeksoup/ stock research
Stock research / United States / AXSM / Planned sales

Axsome Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Axsome Therapeutics, Inc. filed 32 Form 144 notices of planned sales, 756,793 shares worth $134.9 million at the time of filing, from 8 sellers. The latest, filed 3 September 2026: Mark Jacobson (officer), 10,000 shares worth $2.1 million, planned for around 3 September 2026 through Goldman Sachs & Co. LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
3 September 2026Mark JacobsonOfficer10,000$2.1 million3 September 202610,000 shares from 3 September 2026Goldman Sachs & Co. LLCStock OptionsForm 144
6 August 2026Herriot TabuteauOfficer4,660$979,2066 August 202649,664 shares from 5 August 2026Goldman Sachs & Co. LLCStock OptionsForm 144
5 August 2026Herriot TabuteauOfficer45,004$9.6 million5 August 2026None on Form 4 yetGoldman Sachs & Co. LLCStock OptionsForm 144
1 July 2026Herriot TabuteauOfficer49,666$12.0 million1 July 202649,666 shares from 1 July 2026Goldman Sachs & Co. LLCStock OptionsForm 144
11 June 2026Jeffs RogerDirector286$71,24811 June 2026572 shares from 10 June 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
10 June 2026Jeffs RogerDirector286$70,40710 June 2026No matching Form 4 saleCharles Schwab & Co., Inc.Restricted Stock LapseForm 144
10 June 2026Mahony SusanDirector300$73,85410 June 2026600 shares from 9 June 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
10 June 2026Coleman MarkDirector643$160,10910 June 2026643 shares from 10 June 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
9 June 2026Mahony SusanDirector300$71,1639 June 2026No matching Form 4 saleCharles Schwab & Co., Inc.Restricted Stock LapseForm 144
9 June 2026Pizzie NickOfficer33,000$7.9 million9 June 202633,000 shares from 9 June 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
9 June 2026Herriot TabuteauOfficer49,670$12.2 million9 June 202649,670 shares from 9 June 2026Goldman Sachs & Co. LLCStock OptionsForm 144
2 June 2026Coleman MarkDirector5,537$1.2 million2 June 202611,537 shares from 1 June 2026Charles Schwab & Co., Inc.Exercise and HoldForm 144
1 June 2026Coleman MarkDirector6,000$1.4 million1 June 2026No matching Form 4 saleCharles Schwab & Co., Inc.Exercise and HoldForm 144
29 May 2026Coleman MarkDirector6,000$1.4 million29 May 20266,000 shares from 29 May 2026Charles Schwab & Co., Inc.Exercise and HoldForm 144
5 May 2026Mark JacobsonOfficer233$51,9735 May 20264,750 shares from 4 May 2026Goldman Sachs & Co. LLCStock OptionsForm 144
4 May 2026Mark JacobsonOfficer4,517$1.0 million4 May 2026No matching Form 4 saleGoldman Sachs & Co. LLCStock OptionsForm 144
22 April 2026Maizel AriOfficer7,500$1.4 million22 April 20267,500 shares from 22 April 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
26 February 2026Coleman MarkDirector25,000$4.0 million26 February 202625,000 shares from 26 February 2026Charles Schwab & Co., Inc.Exercise and HoldForm 144
26 February 2026Mark JacobsonOfficer35,378$5.8 million26 February 202635,378 shares from 26 February 2026Goldman Sachs & Co. LLCStock OptionsForm 144
2 February 2026Herriot TabuteauOfficer32,410$6.0 million2 February 202632,410 shares from 2 February 2026Goldman Sachs & Co. LLCStock OptionsForm 144
22 January 2026Pizzie NickOfficer12,000$2.3 million22 January 202612,000 shares from 22 January 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
21 January 2026Maizel AriOfficer7,500$1.4 million21 January 20267,500 shares from 21 January 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
7 January 2026Herriot TabuteauOfficer31,261$5.3 million7 January 202660,711 shares from 6 January 2026Goldman Sachs & Co. LLCStock OptionsForm 144
6 January 2026Herriot TabuteauOfficer29,450$5.1 million6 January 202678,703 shares from 5 January 2026Goldman Sachs & Co. LLCStock OptionsForm 144
5 January 2026Herriot TabuteauOfficer78,703$13.5 million5 January 2026No matching Form 4 saleGoldman Sachs & Co. LLCStock OptionsForm 144
31 December 2025Saad Mark EDirector37,577$6.2 million31 December 202537,577 shares from 31 December 2025Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
4 December 2025Herriot TabuteauOfficer10,558$1.6 million4 December 202530,721 shares from 3 December 2025Goldman Sachs & Co. LLCStock OptionsForm 144
3 December 2025Herriot TabuteauOfficer20,163$3.0 million3 December 202549,252 shares from 2 December 2025Goldman Sachs & Co. LLCStock OptionsForm 144
2 December 2025Herriot TabuteauOfficer49,252$7.0 million2 December 2025No matching Form 4 saleGoldman Sachs & Co. LLCStock OptionsForm 144
5 November 2025Herriot TabuteauOfficer21,775$3.0 million5 November 202572,234 shares from 4 November 2025Goldman Sachs & Co. LLCStock OptionsForm 144
4 November 2025Herriot TabuteauOfficer50,459$6.8 million4 November 202591,705 shares from 3 November 2025Goldman Sachs & Co. LLCStock OptionsForm 144
3 November 2025Herriot TabuteauOfficer91,705$12.4 million3 November 2025No matching Form 4 saleGoldman Sachs & Co. LLCStock OptionsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?